AVX Pharma Overview
- Founded
-
2013

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
AVX Pharma General Information
Description
Developer of medicinal drugs designed to offer treatment for ophthalmic diseases. The company's drugs focuses on ocular surface diseases by providing advanced medicinal products, enabling patients to recover faster from dry eye syndrome.
Contact Information
Website
www.avxpharma.com
Formerly Known As
Avizorex Pharma
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
- Parc Científic de Barcelona
- C/Baldiri Reixac 4-8, Torre R
- 08028 Barcelona
- Spain
AVX Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
AVX Pharma Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of medicinal drugs designed to offer treatment for ophthalmic diseases. The company's drugs focuses on ocular
Biotechnology
Barcelona, Spain
00.000
00.00
0000-00-00
000000&0
00.000
AVX Pharma Competitors (19)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
PanOptica | Venture Capital-Backed | Mount Arlington, NJ | 0 | 0000 | 00000000000 | 0000 |
000000000 00000000 | Venture Capital-Backed | Rockville, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
000 000000000000 | Venture Capital-Backed | Ann Arbor, MI | 00 | 000.00 | 00000000000 | 000.00 |
00000000 | Venture Capital-Backed | Vienna, Austria | 00.00 | 0000000000 | 00.00 | |
0000000 0000000000 | Formerly VC-backed | Boston, MA | 00 | 00000 | 000000000 | 00000 |
AVX Pharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|